SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/5573AB95D3869BA6B1AB3307D78326456DB274E89C8DFD5202099595B498C6FC6E59707944208960E95BFB6BA31C28DB>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/5573AB95D3869BA6B1AB3307D78326456DB274E89C8DFD5202099595B498C6FC6E59707944208960E95BFB6BA31C28DB
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/5573AB95D3869BA6B1AB3307D78326456DB274E89C8DFD5202099595B498C6FC6E59707944208960E95BFB6BA31C28DB
http://www.w3.org/2000/01/rdf-schema#comment
"data illustrated the therapeutic potential for 3'-O-methylorobol for histamine-dependent itching and the small molecule inhibition of Nav1.7 may represent a useful strategy to develop novel therapeutics for itching."
xsd:string
http://purl.uniprot.org/uniprot/#_EBB400C346DFEBC800A26E9DD823FD97ED554A64FBFDDDE4E7304FF71DB3CC4992145A7D6A00A9DADE823F0C119264F6
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/5573AB95D3869BA6B1AB3307D78326456DB274E89C8DFD5202099595B498C6FC6E59707944208960E95BFB6BA31C28DB
http://purl.uniprot.org/uniprot/B2RY06
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/5573AB95D3869BA6B1AB3307D78326456DB274E89C8DFD5202099595B498C6FC6E59707944208960E95BFB6BA31C28DB
http://purl.uniprot.org/uniprot/#_B2RY06-mappedCitation-31805638
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/5573AB95D3869BA6B1AB3307D78326456DB274E89C8DFD5202099595B498C6FC6E59707944208960E95BFB6BA31C28DB